NLM Logo

Levamisole MeSH Descriptor Data 2025


MeSH Heading
Levamisole
Tree Number(s)
D02.886.675.346
D03.383.129.308.480
D03.383.129.708.346
Unique ID
D007978
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D007978
Scope Note
An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6)
Entry Term(s)
Decaris
Dekaris
L-Tetramisole
Levamisole Hydrochloride
Levotetramisole
Solaskil
Pharm Action
Adjuvants, Immunologic
Antinematodal Agents
Antirheumatic Agents
Related Numbers
14769-73-4
16595-80-5
DL9055K809
CAS Type 1 Name
Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, (S)-
Public MeSH Note
74
History Note
74
Date Established
1974/01/01
Date of Entry
1999/01/01
Revision Date
2016/05/31
Levamisole Preferred
Dekaris Narrower
Levamisole Hydrochloride Narrower
Solaskil Narrower
page delivered in 0.203s